Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
For the full drug overview including availability timeline, see the complete retatrutide guide
The SCALE Obesity and Prediabetes trial (N=3,731) showed a mean 8.0% weight loss at 56 weeks versus 2.6% for placebo, with 63.2% of participants achieving 5% weight loss [12]
Retatrutide is a next-generation tri-agonist peptide developed for advanced metabolic research
Glutathione treatment should be discontinued immediately if unusual symptoms appear after therapy
Develop personalized treatment algorithms incorporating novel BBR-responsive biomarkers
.png)
US$ 26.85
US$ 25.46
US$ 24.95
US$ 24.22
